Skip to content
IP Osgoode
  • ABOUT
  • OUR TEAM
    • DIRECTOR
    • MEMBERS
    • ADVISORY BOARD
    • SPONSORS
  • IPILOGUE
    • ABOUT THE IPILOGUE
    • BLOG
      • Announcements
      • Artificial Intelligence
      • Copyright
      • Innovation
      • IP Innovation Clinic
      • IP Intensive
      • Patents
      • Privacy
      • Technology
      • Trademarks
    • IPILOGUE TEAM
    • GOWLING WLG PRIZE
    • IPIGRAM ARCHIVE
    • WRITE FOR US
  • IP INNOVATION CLINIC
    • ABOUT
    • CHATBOT
    • BECOME A CLIENT
    • CLINIC FELLOWS
    • THE IP LUNCH CLUB
    • FAQS
  • IP INTENSIVE
    • ABOUT
    • PLACEMENTS
  • RESEARCH
    • IP LAW & POLICY
    • INNOVATION
    • LAW REFORM
  • EVENTS
    • UPCOMING EVENTS
    • PAST EVENTS
  • CONTESTS & COMPETITIONS
    • 2021 Oxford International Intellectual Property Law Moot
    • WIPO Short Story Competition: Indigenous Ingenuity and Creativity
    • IP WRITING CHALLENGE
    Home
    >
    Medical

    Tag: Medical

    March 3, 2022in Blogs, IP, Patentability, Patents, Technology0by Editor
    1037

    Easy, Breezy, Bioprintable: 3D Printing in the Cosmetics Industry

      Emily Xiang is an IPilogue Writer, President of the Intellectual Property Society of Osgoode, and a 2L JD candidate at Osgoode Hall Law School.   What is Bioprinting? Bioprinting…

    Read more
    December 3, 2021in Blogs, IP, IP Intensive, Patents, Pharmaceutical Drugs0by Editor
    1736

    What is a Method of Medical Treatment?

    David Park is a 3L J.D. Candidate at Osgoode Hall Law School, enrolled in Professor David Vaver’s 2021-2022 Intellectual Property Law & Technology Intensive Program. As part of the course…

    Read more
    AI or Human Doctor?
    May 14, 2020in Blogs1by Editor
    2136

    AI or Human Doctor?

    This post is a response to the following question, initially posed to students in the Legal Values: Artificial Intelligence seminar: “You are not feeling well and need to see a…

    Read more
    February 24, 2012in IP, Pharmaceutical Drugs1by Editor
    2170

    WHO Resolution Intended to Address Global Counterfeit Drug Market

    On January 21, the WHO 130th WHO Executive Board (EB) adopted a resolution for agenda item 6.13 “substandard/spurious/falsely-labelled/falsified/counterfeit medical products” [SFFC]. The resolution is intended to address the growing prevalence…

    Read more
    Search
      Categories
      IP Osgoode
      © Osgoode Hall Law School, York University
      • Privacy & Legal
      Osgoode Hall Law School, York University
      Ignat Kaneff Building
      4700 Keele Street
      Toronto, Ontario  M3J 1P3
      Canada

      T:416.736.5030   F:416.736.5736